Marimed (MRMD) Gross Profit (2011 - 2026)

Marimed (MRMD) has 16 years of Gross Profit data on file, last reported at $15.3 million in Q1 2026.

• On a quarterly basis, Gross Profit rose 1.24% year-over-year to $15.3 million in Q1 2026; TTM through Mar 2026 was $58.2 million, a 5.31% decrease from a year earlier, with the FY2025 full-year figure at $57.9 million, down 7.56% from the prior year.
• Gross Profit for Q1 2026 stood at $15.3 million, up from $10.5 million in the prior quarter.
• Over the last five years, Gross Profit for MRMD reached as high as $17.3 million in Q4 2023 and fell as low as $10.5 million in Q4 2025.
• Historically, Gross Profit has averaged $15.6 million across 5 years, with a median of $16.2 million in 2022.
• Across the five-year window, Gross Profit grew 28.74% in 2022 and slipped 26.92% in 2024, its largest moves.
• Year by year, Gross Profit stood at $15.8 million in 2022, then gained by 9.52% to $17.3 million in 2023, then slipped by 26.92% to $12.7 million in 2024, then declined by 17.02% to $10.5 million in 2025, then soared by 45.46% to $15.3 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $15.3 million in Q1 2026, $10.5 million in Q4 2025, and $16.4 million in Q3 2025.